Selected research
Industry Research
Type 2 Diabetes Mellitus Treatment Industry Research Report 2026
Market perspective
The global Type 2 Diabetes Mellitus Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Type 2 Diabetes Mellitus Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Type 2 Diabetes Mellitus Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Type 2 Diabetes Mellitus Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Type 2 Diabetes Mellitus Treatment include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Type 2 Diabetes Mellitus Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Type 2 Diabetes Mellitus Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Type 2 Diabetes Mellitus Treatment Market by Company
Takeda Pharmaceutical Co. Ltd
Sanofi SA
Novartis AG
Novo Nordisk AS
Merck & Co. Inc
Eli Lilly and Co.
Daiichi Sankyo Co. Ltd
Boehringer Ingelheim International GmbH
AstraZeneca PLC
Type 2 Diabetes Mellitus Treatment Segment by Type
Insulin
SGLT2 Inhibitors
GLP-1 Receptor Agonists
DPP-4 Inhibitors
Others
Type 2 Diabetes Mellitus Treatment Segment by Application
Hospitals
Clinics
Other
Type 2 Diabetes Mellitus Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Type 2 Diabetes Mellitus Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Insulin
- SGLT2 Inhibitors
- GLP-1 Receptor Agonists
- DPP-4 Inhibitors
- Others
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Takeda Pharmaceutical Co. Ltd
- Sanofi SA
- Novartis AG
- Novo Nordisk AS
- Merck & Co. Inc
- Eli Lilly and Co.
- Daiichi Sankyo Co. Ltd
- Boehringer Ingelheim International GmbH
- AstraZeneca PLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Type 2 Diabetes Mellitus Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Insulin
- 2.2.3 SGLT2 Inhibitors
- 2.2.4 GLP-1 Receptor Agonists
- 2.2.5 DPP-4 Inhibitors
- 2.2.6 Others
- 2.3 Type 2 Diabetes Mellitus Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Type 2 Diabetes Mellitus Treatment Breakdown Data by Type
- 3.1 Global Type 2 Diabetes Mellitus Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Type (2027-2032)
4 Type 2 Diabetes Mellitus Treatment Breakdown Data by Application
- 4.1 Global Type 2 Diabetes Mellitus Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Type 2 Diabetes Mellitus Treatment Market Perspective (2021-2032)
- 5.2 Global Type 2 Diabetes Mellitus Treatment Growth Trends by Region
- 5.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Type 2 Diabetes Mellitus Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Type 2 Diabetes Mellitus Treatment Market Dynamics
- 5.3.1 Type 2 Diabetes Mellitus Treatment Industry Trends
- 5.3.2 Type 2 Diabetes Mellitus Treatment Market Drivers
- 5.3.3 Type 2 Diabetes Mellitus Treatment Market Challenges
- 5.3.4 Type 2 Diabetes Mellitus Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Type 2 Diabetes Mellitus Treatment Players by Revenue
- 6.1.1 Global Top Type 2 Diabetes Mellitus Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Type 2 Diabetes Mellitus Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Type 2 Diabetes Mellitus Treatment Head Office and Area Served
- 6.4 Global Type 2 Diabetes Mellitus Treatment Players, Product Type & Application
- 6.5 Global Type 2 Diabetes Mellitus Treatment Manufacturers Established Date
- 6.6 Global Type 2 Diabetes Mellitus Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
- 7.2 North America Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
- 7.4 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
- 8.2 Europe Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
- 8.4 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
- 10.2 South America Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
- 10.4 South America Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Takeda Pharmaceutical Co. Ltd
- 12.1.1 Takeda Pharmaceutical Co. Ltd Company Information
- 12.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
- 12.1.3 Takeda Pharmaceutical Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
- 12.2 Sanofi SA
- 12.2.1 Sanofi SA Company Information
- 12.2.2 Sanofi SA Business Overview
- 12.2.3 Sanofi SA Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.2.5 Sanofi SA Recent Developments
- 12.3 Novartis AG
- 12.3.1 Novartis AG Company Information
- 12.3.2 Novartis AG Business Overview
- 12.3.3 Novartis AG Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.3.5 Novartis AG Recent Developments
- 12.4 Novo Nordisk AS
- 12.4.1 Novo Nordisk AS Company Information
- 12.4.2 Novo Nordisk AS Business Overview
- 12.4.3 Novo Nordisk AS Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.4.5 Novo Nordisk AS Recent Developments
- 12.5 Merck & Co. Inc
- 12.5.1 Merck & Co. Inc Company Information
- 12.5.2 Merck & Co. Inc Business Overview
- 12.5.3 Merck & Co. Inc Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.5.5 Merck & Co. Inc Recent Developments
- 12.6 Eli Lilly and Co.
- 12.6.1 Eli Lilly and Co. Company Information
- 12.6.2 Eli Lilly and Co. Business Overview
- 12.6.3 Eli Lilly and Co. Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.6.5 Eli Lilly and Co. Recent Developments
- 12.7 Daiichi Sankyo Co. Ltd
- 12.7.1 Daiichi Sankyo Co. Ltd Company Information
- 12.7.2 Daiichi Sankyo Co. Ltd Business Overview
- 12.7.3 Daiichi Sankyo Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.7.5 Daiichi Sankyo Co. Ltd Recent Developments
- 12.8 Boehringer Ingelheim International GmbH
- 12.8.1 Boehringer Ingelheim International GmbH Company Information
- 12.8.2 Boehringer Ingelheim International GmbH Business Overview
- 12.8.3 Boehringer Ingelheim International GmbH Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.8.5 Boehringer Ingelheim International GmbH Recent Developments
- 12.9 AstraZeneca PLC
- 12.9.1 AstraZeneca PLC Company Information
- 12.9.2 AstraZeneca PLC Business Overview
- 12.9.3 AstraZeneca PLC Revenue in Type 2 Diabetes Mellitus Treatment Business (2021-2026)
- 12.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
- 12.9.5 AstraZeneca PLC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst